1. Chemotherapy at First Diagnosis of Advanced Prostate Cancer – Revolution or Evolution? Findings from a British Uro-oncology Group UK Survey to Evaluate Oncologists' Views on First-line Docetaxel in Combination with Androgen Deprivation Therapy in Castrate-sensitive Metastatic and High-risk/Locally Advanced Prostate Cancer. Issue 6 (June 2016) Authors: Davda, R.; Hughes, S.; Jones, R.; Crabb, S.J.; Troup, J.; Payne, H. Journal: Clinical oncology Issue: Volume 28:Issue 6(2016) Page Start: 376 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical outcomes following neoadjuvant cisplatin‐based chemotherapy for bladder cancer in elderly compared with younger patients. (25th January 2015) Authors: Chau, C.; Wheater, M.; Geldart, T.; Crabb, S.J. Journal: European journal of cancer care Issue: Volume 24:Number 2(2015:Mar.) Page Start: 155 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Platinum-Based Chemotherapy 'Rechallenge' in Advanced Non-ovarian Solid Malignancies. Issue 8 (August 2022) Authors: Hack, J.; Crabb, S.J. Journal: Clinical oncology Issue: Volume 34:Issue 8(2022) Page Start: e329 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The National Institute for Health and Care Excellence (NICE) Guidance on Bladder Cancer; a Step in the Right Direction?. Issue 6 (June 2017) Authors: Trainor, S.; Choudhury, A.; Huddart, R.; Kiltie, A.E.; Kockelbergh, R.; Turner, W.; Birtle, A.; Crabb, S.J. Journal: Clinical oncology Issue: Volume 29:Issue 6(2017) Page Start: 344 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗